Trial intelligence / Profile preview

Remimazolam vs Propofol with Esketamine for Painless Abortion

NCT05635955Phase 2Completed

Sponsor
Maternal and Child Health Hospital of Hubei Province
Start
Aug 2022
Primary completion
Sep 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of remimazolam, sponsored by Maternal and Child Health Hospital of Hubei Province. Started Aug 2022; status: completed.

02

Drugs

remimazolam

Beyond the preview

Go deeper on NCT05635955.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05635955.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call